US Patent Issued to Nanjing Leads Biolabs on Sept. 1 for "Antibodies binding 4-1BB and uses thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,086, issued on Sept. 1, was assigned to Nanjing Leads Biolabs Co. Ltd. (Nanjing, China).

"Antibodies binding 4-1BB and uses thereof" was invented by Xiaoqiang Kang (Plainsboro, N.J.), Xiao Huang (Nanjing, China) and Jianming Sun (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is an isolated monoclonal antibody that specifically binds human 4-1BB, or the antigen-binding portion thereof. A nucleic acid molecule encoding the antibody, an expression vector, a host cell and a method for expressing the antibody are also provided. The present disclosure further provides a bispecific molecule, and a pharmaceutical composition compri...